Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorio Farmaceutico Quimico Lafarquim SA
Original Assignee
Laboratorio Farmaceutico Quimico Lafarquim SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Farmaceutico Quimico Lafarquim SAfiledCriticalLaboratorio Farmaceutico Quimico Lafarquim SA
Priority to ES396028ApriorityCriticalpatent/ES396028A1/en
Publication of ES396028A1publicationCriticalpatent/ES396028A1/en
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Abstract
Process for obtaining fluracepan palmitate, characterized in that the reactants are fluracepan hydrochloride and a water-soluble salt of palmitic acid (sodium, potassium, ammonium salt, etc.) in aqueous solution, obtaining as products the fliracepan palmitate and the corresponding chloride. (Machine-translation by Google Translate, not legally binding)
ES396028A1971-10-151971-10-15Procedure for obtaining palmitate from fluracepan. (Machine-translation by Google Translate, not legally binding)
ExpiredES396028A1
(en)
Procedure for obtaining a new derivative of 6-aminopenicilanic acid and its non-toxic salts. (Machine-translation by Google Translate, not legally binding)
PROCESS FOR THE PREPARATION OF 3-AMINOALKYL-3-ARYLINDAN-1-OLE AND THEIR ACID ADDITIONAL SALTS AND SODIUM AND POTASSIUM SALTS, AS WELL AS OF 1-AMINOALKYL-1-ARYLINDEN.
Procedure for obtaining a salt of acid 2,2'-dihydroxy-1,1'-dinaftilmetano-3,3'-dicarboxilico, of pharmaceutical application. (Machine-translation by Google Translate, not legally binding)